Medication info
Dapazine SDUO Tablet 10/100 mg (Dapagliflozin, Sitagliptin)

Dapazine SDUO Tablet 10/100 mg (Dapagliflozin, Sitagliptin)

Prescription medicationTablet
Ingredient · strength
Dapagliflozin Bis L-proline›15.63mg / 1 tabletSitagliptin Phosphate Hydrate›128.48mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
28 tablets/box [(7 tablets/PTP) X 4]
Approval status
Active

MFDS item code 202301844 · Approved 2023.06.15 · Insurance code 648104910

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
Patients receiving sitagliptin 100 mg and dapagliflozin 10 mg may take 1 tablet once daily, with or without food. The tablet should be swallowed whole. Patients with renal impairment The efficacy and safety of this medicine depend on renal function. It is recommended that renal function be assessed before treatment with this medicine and periodically thereafter. - No dosage adjustment is required when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. - This medicine should not be administered when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2. Patients with hepatic impairment No dosage adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps control blood sugar levels in patients with type 2 diabetes by using sitagliptin and dapagliflozin together. It aids in effectively managing blood glucose levels in conjunction with dietary and exercise regimens. This contributes to the prevention of diabetes complications and maintaining a healthy lifestyle.

Dosage and Administration

Adult dosage

Patients receiving sitagliptin 100 mg and dapagliflozin 10 mg may take 1 tablet once daily, with or without food. The tablet should be swallowed whole. Patients with renal impairment The efficacy and safety of this medicine depend on renal function. It is recommended that renal function be assessed before treatment with this medicine and periodically thereafter. - No dosage adjustment is required when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. - This medicine should not be administered when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2. Patients with hepatic impairment No dosage adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Precautions

This drug may cause severe allergic reactions due to the sitagliptin component, so it should be discontinued immediately if symptoms such as skin rash, angioedema, or difficulty breathing occur within three months of administration. Additionally, acute pancreatitis may occur, so if symptoms like abdominal pain, nausea, or vomiting arise, prompt consultation with a healthcare provider is advised. This drug should not be used in patients with allergies to the active ingredient or excipients, patients with type 1 diabetes, patients with a genetic lactose intolerance, and patients undergoing dialysis. It should be administered cautiously in patients with reduced fluid volume or kidney function impairment, especially elderly patients or those on diuretics, as they may have a higher risk of lowering blood pressure and kidney damage. The blood sugar control effect may vary based on kidney function, and it is not recommended for patients with severe kidney impairment. This medication may increase the risk of genital infections and urinary tract infections, so patients should receive immediate treatment if symptoms of infection appear, and those with a history of infections should be more vigilant. There is a risk of hypoglycemia; therefore, dose adjustment may be necessary when used in combination with insulin or sulfonylureas. Furthermore, weight loss may occur, and it is crucial to regularly assess kidney function in elderly patients. Use during pregnancy is not recommended, and administration should be avoided while breastfeeding. In case of overdose, there is no specific antidote, so symptomatic treatment is necessary, and emergency medical attention should be sought in severe cases. While taking this medication, caution is required for symptoms of hypoglycemia when driving or operating machinery. Finally, this medication should be kept out of the reach of children, and proper storage conditions should be maintained to preserve product quality.

Side effects

  • Severe allergic reaction
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hemorrhagic pancreatitis
  • necrotizing pancreatitis
  • genital infections
  • vulvitis
Show 113 more
  • balanitis
  • fungal infections
  • perineal necrosis
  • hypoglycemia
  • reduced fluid volume
  • thirst
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • vulvar pruritus
  • genital pruritus
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • increased serum creatinine
  • elevated blood urea
  • weight loss
  • urinary tract infection
  • cystitis
  • Escherichia coli urinary tract infection
  • urogenital infection
  • pyelonephritis
  • cystitis
  • urethritis
  • kidney infection
  • prostatitis
  • acute pyelonephritis
  • rash
  • generalized rash
  • pruritic rash
  • maculopapular rash
  • vesicular rash
  • pustular rash
  • bullous rash
  • erythematous rash
  • asthenia
  • pain
  • ligament sprain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • hemorrhagic stroke
  • peripheral artery occlusion
  • angina pectoris
  • myocardial infarction
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • paresthesia
  • cerebral infarction
  • nerve compression
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • vaginal discharge
  • menstrual irregularities
  • itching
  • urticaria
  • cold sweat
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • myopathy
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic retinopathy
  • cough
  • dyspnea
  • orthostatic hypotension
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyp
  • tinnitus
  • pneumonia
  • pulmonary tuberculosis
  • vascular headache
  • orthostatic hypotension
  • anxiety disorder
  • enuresis
  • hallucinations
  • sleep disorder
  • bile duct stone
  • cholangitis
  • alcoholic cirrhosis
  • liver cyst
  • dizziness
  • anal-genital warts
  • gastric adenoma
  • neuroma
  • pituitary neoplasm unspecified
  • male reproductive gland hypofunction
  • thyroid cyst
  • thyroid nodule
  • food allergy
  • polycythemia.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, and it is best kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

28 tablets/box [(7 tablets/PTP) X 4]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.